返回
Zhaoke Ophthalmology Limited（06622.HK）价格
06622.HK 股价走势图
ZHAOKE OPHTH-B (06622.HK)
Zhaoke Ophthalmology Limited
HK$3.52
-0.84%
$-0.02
休市： Jan 16, 16:00:00 HKT
关键数据
前收盘价
$3.55
开盘价
$3.55
当日区间
$3.49 - $3.55
52周范围
$1.26 - $4.6
交易量
393.5K
平均成交量
1.0M
每股收益（TTM）
-0.56
股息收益率
--
市值
$1.9B
什么是 ZHAOKE OPHTH-B？
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. The company is headquartered in Guangzhou, Guangdong and currently employs 270 full-time employees. The company went IPO on 2021-04-29. The product pipelines primarily include NVK002 (Atropine) for myopia, CsA Ophthalmic Gel for DED and TAB014 (Bevacizumab) for wAMD. The products are primarily uses to treat eye diseases across both the front and the back of the eye, including dry eye disease (DED), myopia, presbyopia, wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), glaucoma and corneal epithelial dysfunction (CED). The firm conducts its business in the domestic market and overseas markets.
